The current valuation score of Greenwich Lifesciences Inc is 8.99, ranking 34 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -9.19, which is -41.85% below the recent high of -5.34 and -273.65% above the recent low of -34.33.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.